Cannlabs Stock Price, News & Analysis
Company Description
Cannlabs (OTC Link: CANL) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $509.5K.
This page provides a comprehensive overview of CANL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cannlabs (CANL) stock last traded at $0.0001. At a market capitalization of $509.5K, CANL is classified as a micro-cap stock with approximately 813.2M shares outstanding.
Latest News
Cannlabs has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CANL news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Cannlabs (CANL) currently stands at 392 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Cannlabs (CANL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.1 days.
CANL Company Profile & Sector Positioning
Cannlabs (CANL) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CANL often look at related companies in the same sector, including MAVEN BRANDS INC (TRLFF), Gelstat Corp (GSAC), Vibe Growth Corporation (VIBEF), Demand Brands Inc (DMAN), and Aequus Pharmaceu (AQSZF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CANL's relative position within its industry.